3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Prostatic Neoplasms
8
Leukemia
8
Burkitt Lymphoma
7
Recurrence
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Rhabdoid Tumor
1
Plasmablastic Lymphoma
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Leukemia, T-Cell
1
Leukemia, Mast-Cell
1
Leukemia, Lymphoid
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Hydrocortisone
×
Clear all
No trials found.